respiratory distress syndrome, surfactant treatment, premedication
Conditions
Brief summary
Any adverse event (the need of positive pressure ventilation, intubation, heart rate below 80/min, mean arterial pressure change more than 20%, pH change more than 0.4, CO2 change more than 20%, and saturation <85 for more than 1 minute)
Detailed description
Duration of the procedure, Number of attempts to get the catether intratracheally, Pain score NIAPAS, The need for additional dosing of study drug or midazolam (number of addtional dosages), Edi-signals
Interventions
DRUGFentanyl-hameln 50 Mikrogramm/ml Injektionslösung
DRUGKetanest-S 5 mg/ml injektio-/infuusioneste
DRUGliuos
Sponsors
Pohjois-Pohjanmaan hyvinvointialue, University Of Oulu
Eligibility
Sex/Gender
All
Age
0 Years to 17 Years
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Any adverse event (the need of positive pressure ventilation, intubation, heart rate below 80/min, mean arterial pressure change more than 20%, pH change more than 0.4, CO2 change more than 20%, and saturation <85 for more than 1 minute) | — |
Secondary
| Measure | Time frame |
|---|---|
| Duration of the procedure, Number of attempts to get the catether intratracheally, Pain score NIAPAS, The need for additional dosing of study drug or midazolam (number of addtional dosages), Edi-signals | — |
Countries
Finland
Outcome results
None listed